首页> 外文期刊>Journal of the American College of Surgeons >Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis.
【24h】

Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis.

机译:肉眼可见门静脉肿瘤血栓形成的肝细胞癌的手术结果。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The longterm results after liver resection for hepatocellular carcinoma with macroscopic tumor thrombus of the portal vein are unclear. STUDY DESIGN: The records of 47 HCC patients with tumor thrombus in the segmental portal branch (n = 33) and the first portal branch or portal vein trunk (n = 14) were reviewed in this study. Survival rates of the patients were calculated with regard to 14 dinicopathologic variables. A log-rank analysis was performed to identify which variables predicted the prognosis. RESULTS: Overall 1-, 3-, and 5-year survival rates were 53.9%, 33.2%, and 23.9%, respectively. The indicators of a favorable prognosis included curative liver resection, tumor size less than 10 cm in diameter, and absence of intrahepatic metastases. CONCLUSIONS: Liver resection should be considered a therapeutic option for hepatocellular carcinoma with macroscopic portal vein tumor thrombus when the tumor is small and curative liver resection can be expected.
机译:背景:肝癌切除术后门静脉宏观血栓形成的长期结果尚不清楚。研究设计:本研究回顾了47例HCC患者的肿瘤血栓,这些患者在节段门分支(n = 33)和第一个门分支或门静脉主干(n = 14)中记录。根据14个病理学变量计算患者的存活率。进行对数秩分析以确定哪些变量预测了预后。结果:总体1年,3年和5年生存率分别为53.9%,33.2%和23.9%。预后良好的指标包括根治性肝切除,肿瘤直径小于10 cm以及无肝内转移。结论:当肿瘤较小且可望治愈的肝切除术时,肝切除术应被认为是伴有门静脉大血栓的肝细胞癌的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号